These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2635703)

  • 1. [A new concept in the treatment of gastrointestinal diseases--Propulsin. Workshop, Beerse, Belgium, 16 June 1989].
    Internist (Berl); 1989 Sep; 30(9 Suppl):1-15. PubMed ID: 2635703
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases].
    Ryss ES; Fishzon-Ryss IuI
    Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263
    [No Abstract]   [Full Text] [Related]  

  • 3. Cisapride: its use in children.
    Newell SJ
    Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prokinetic drugs].
    Hellström P
    Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional disorders of the digestive tract and possibilities of therapy with Prepulside (cisapride)].
    Hep A; Prásek J; Dítĕ P
    Vnitr Lek; 1995 Mar; 41(3):199-203. PubMed ID: 7762181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is assured in therapy of gastrointestinal diseases with drugs acting on motility?].
    Müller-Lissner S; Klauser A
    Internist (Berl); 1989 Dec; 30(12):797-804. PubMed ID: 2695489
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic-obstructive upper abdominal complaints. Outlook. Further hypothetical indications].
    Fortschr Med Suppl; 1990; 87():15-6. PubMed ID: 2190899
    [No Abstract]   [Full Text] [Related]  

  • 8. Cisapride, a drug for long-term treatment?
    Harvengt C
    Acta Gastroenterol Belg; 1990; 53(4):369-71. PubMed ID: 2096582
    [No Abstract]   [Full Text] [Related]  

  • 9. Placebo-controlled trial of cisapride in postoperative ileus.
    Boghaert A; Haesaert G; Mourisse P; Verlinden M
    Acta Anaesthesiol Belg; 1987; 38(3):195-9. PubMed ID: 3321849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse gastrointestinal dysmotility in a patient with rheumatoid arthritis.
    Ljubich P; Parkman HP; Fisher RS; Sorokin JJ; Conaway DC
    Am J Gastroenterol; 1993 Sep; 88(9):1443-5. PubMed ID: 8362846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cisapride--a new drug effective in the treatment of disorders of gastrointestinal motility].
    Kasicka A; Jonderko K
    Przegl Lek; 1989; 46(3):356-9. PubMed ID: 2672116
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisapride therapy for gastrointestinal disease.
    Cucchiara S
    J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):259-69. PubMed ID: 8708879
    [No Abstract]   [Full Text] [Related]  

  • 13. Cisapride.
    Menezes O
    Aust Nurses J; 1991 Oct; 21(4):27. PubMed ID: 1750810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cisapride--help for motility disorders. Selective enhancement of motility for the entire gastrointestinal tract].
    Fortschr Med Suppl; 1989; 75():1-15. PubMed ID: 2635681
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 16. Moving ahead or falling behind?
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jun; 4(6):295. PubMed ID: 17541443
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of postoperative gastrointestinal atony.
    Verlinden M; Michiels G; Boghaert A; de Coster M; Dehertog P
    Br J Surg; 1987 Jul; 74(7):614-7. PubMed ID: 3620873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisapride. A new agent which stimulates gastrointestinal motility].
    Husebye E
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):981-2. PubMed ID: 2321233
    [No Abstract]   [Full Text] [Related]  

  • 19. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder.
    Camilleri M; Balm RK; Zinsmeister AR
    Gastroenterology; 1994 Apr; 106(4):916-23. PubMed ID: 8143996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology of an anticholinergic Sch-3444 or 4-(1-methyl-piperidyl)benzilate methylbromide. Experimental and clinical study].
    Maggi ND; Camponovo LE; Marchese MJ; Bertorello MC
    Prensa Med Argent; 1967 Apr; 54(8):375-9. PubMed ID: 5628940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.